Maze Insider Reports $736K Sale. Here's What Investors Should Know as Stock Plunges 33%

An executive at Maze Therapeutics sold 15,000 shares on March 20, 2026 for $736,000 total (~$49.10 per share). The transaction was a direct sale executed via option exercise (derivative mechanics) and did not affect any indirect holdings; it appears to be routine insider liquidity rather than material company news.

Analysis

An executive at Maze Therapeutics sold 15,000 shares on March 20, 2026 for $736,000 total (~$49.10 per share). The transaction was a direct sale executed via option exercise (derivative mechanics) and did not affect any indirect holdings; it appears to be routine insider liquidity rather than material company news.